German medtech developer CoreMedic this week announced the launch of a first-in-man trial of its ChordArt mitral valve repair device, touting the trial as the first of its kind to treat patients with ruptured or elongated mitral chords. The company’s ChordArt implant is designed to replace ruptured or elongated mitral chordae and to re-establish the […]